罗氟司特Daxas可以用于治疗严重慢性阻塞性肺病

Chronic obstructive pulmonary disease (COPD) is a serious lung disease that can cause difficulty breathing. The main symptoms include: asthma, chronic cough, phlegm, etc. An attack can last for several weeks and can lead to reduced lung function, severe anxiety, and even an increased risk of death. It is a new type of drug for the treatment of chronic obstructive pulmonary disease (COPD). It is a phosphodiesterase type 4 (PDE4) inhibitor. This drug is mainly used to treat frequent attacks (exacerbations) or worsening of symptoms of severe chronic obstructive pulmonary disease (COPD), but is not suitable for another type of chronic obstructive pulmonary disease (COPD), namely primary emphysema.

The results of a subgroup analysis showed that compared with the placebo group, roflumilast Daxas had a statistically significant improvement in FEV1 in patients with severe asthma, but similar results were not found in patients with mild asthma. Roflumilast Daxas significantly improved FEV1 in female patients but not in male patients, and the effect of smoking on the lung function-improving effect of this drug was inconsistent. For patients with exercise-induced asthma, roflumilast Daxas also showed an improvement in lung function. Timmer et al. found that compared with placebo, roflumilast Daxas at a dose of 500 μg/day can significantly improve the decrease in FEV1 after exercise.

More than 3,000 patients with chronic obstructive pulmonary disease (COPD) were included in two pivotal placebo-controlled clinical studies. Studies have shown that roflumilast Daxas can significantly improve patients with moderate to severe exacerbations and prediastolic FEV1, regardless of whether it is combined with a long-acting β2 agonist. The study also proved that compared with placebo, roflumilast Daxas can significantly improve patients' lung function.

The above is the introduction to Roflumilast Daxas. If patients want to know more about the latest drug information about this drug (such as the price of Roflumilast Daxas, purchase methods, precautions, etc.), they can contact the Medical Companion Travel Service at any time.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended hot articles: